Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-05-20
2008-05-20
Tsang, Cecilia J. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S330000
Reexamination Certificate
active
11391497
ABSTRACT:
The present invention relates to polypeptides, and nucleic acids DNA encoding these polypeptides, capable of eliciting an immune reaction against cancer, methods for generating T lymphocytes capable of recognizing and destroying tumor cells, and pharmaceutical compositions for the treatment, prophylaxis or diagnosis of cancer.
REFERENCES:
patent: 2006/0106196 (2006-05-01), Gaudernack et al.
patent: 2007/0004632 (2007-01-01), Gaudernack et al.
patent: WO 99/01560 (1999-01-01), None
patent: WO 99/50386 (1999-10-01), None
patent: WO 99/50392 (1999-10-01), None
patent: WO 00/02581 (2000-01-01), None
patent: WO 00/61766 (2000-10-01), None
Gaiger et al. (Blood, vol. 96, No. 4, Aug. 2000, pp. 1480-1489).
Dermer (Bio/Technology, 1994, 12:320).
Wick, M. et al., 1999, Gene 232: 97-106.
Vonderheide, et al., “The Telomerase Catalytic Subunit is a Widely Expressed Tumor-Associated Antigen Recognized by Cytotoxic T Lymphocytes,”Immunity, vol. 10, 1999, pp. 673-679.
Abstract No. 2999 (Vonderheide, et al., “Generation of Telomerase-Specific HLA-A3-Restricted Cytotoxic T Lymphocytes from Patient Blood: Implications for Widely Applicable Anti-cancer Immunotherapy”),Blood, vol. 94, 1999, p. 677a.
Abstract No. 2058 (Vonderheide, et al., “Search for Universal Tumor Antigens: Potential of the Catalytic Telomerase Subunit”),Blood, vol. 92, Supp. 10, 1998, p. 500a.
Wick, et al., “Genomic Organization and Promoter Characterization of the Gene Encoding the Human Telomerase Reverse Transcriptase (hTERT),”Gene, vol. 232, 1999, pp. 97-106.
Dong Seok Kim et al., “Saxatilin, a Snake Venom Disintegrin, Suppresses TNF-α-Induced Ovarian Cancer Cell Invasion,” Journal of Biochemistry and Molecular Biology, Mar. 2007; 40(2): 290-294.
Savita Bisht et al., “Polymeric Nanoparticle-Encapsulated Curcumin (“Nanocurcumin”): A Novel Strategy for Human Cancer Therapy,” Journal of Nanobiotechnology, Apr. 17, 2007; 5(3): http://www.jnanobiotechnology.com/content/5/1/3.
Eriksen Jon Amund
Gaudernack Gustav
Møller Mona
Sæøe-Larssen Stein
Fitzpatrick ,Cella, Harper & Scinto
GemVax AS
Heard Thomas S.
Tsang Cecilia J.
LandOfFree
Polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3911146